We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.14B
AUM Growth
+$467M
(+10%)
Cap. Flow
+$273M
Cap. Flow
% of AUM
5.31%
Top 10 Holdings %
Top 10 Hldgs %
11.46%
Holding
1,074
New
159
Increased
412
Reduced
333
Closed
136
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$28.6M |
| 2 |
AGN
Allergan plc
AGN
|
+$26.5M |
| 3 |
Toro Company
TTC
|
+$22.4M |
| 4 |
PepsiCo
PEP
|
+$20.4M |
| 5 |
Lockheed Martin
LMT
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$26.1M |
| 2 |
Wells Fargo
WFC
|
+$19.4M |
| 3 |
Centene
CNC
|
+$17.3M |
| 4 |
Eli Lilly
LLY
|
+$15.8M |
| 5 |
Kroger
KR
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 18.08% |
| 3 | Industrials | 12.96% |
| 4 | Healthcare | 11.05% |
| 5 | Consumer Discretionary | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Upbound Group
UPBD
$1.19B
| $3.71M | 0.07% |
323,030
+75,630
| +31% | +$935K |
|
302
McDonald's
MCD
$188B
| $3.69M | 0.07% |
23,559
+7,709
| +49% | +$1.21M |
|
|
SHLM
303
DELISTED
Schulman (A.) Inc
SHLM
| $3.68M | 0.07% |
107,698
+7,600
| +8% | +$227K |
|
|
SNBR
304
DELISTED
Sleep Number
SNBR
| $3.68M | 0.07% |
118,411
+4,490
| +4% | +$140K |
|
|
HRC
305
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.66M | 0.07% |
49,514
+17,760
| +56% | +$1.37M |
|
|
AET
306
DELISTED
Aetna Inc
AET
| $3.64M | 0.07% |
22,900
-420
| -2% | -$65.6K |
|
307
Adobe
ADBE
$89.5B
| $3.61M | 0.07% |
24,224
-4,486
| -16% | -$669K |
|
308
S&P Global
SPGI
$126B
| $3.56M | 0.07% |
22,760
+17,050
| +299% | +$2.59M |
|
309
Invitation Homes
INVH
$17.7B
| $3.56M | 0.07% |
+156,997
| New | +$3.48M |
|
|
VCRA
310
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $3.53M | 0.07% |
112,426
+2,110
| +2% | +$58.2K |
|
|
XLNX
311
DELISTED
Xilinx Inc
XLNX
| $3.51M | 0.07% |
49,510
-32,160
| -39% | -$2.1M |
|
|
MNTA
312
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $3.5M | 0.07% |
188,919
+20,590
| +12% | +$344K |
|
313
Genesco
GCO
$396M
| $3.49M | 0.07% |
131,314
-18,950
| -13% | -$536K |
|
|
ABMD
314
DELISTED
Abiomed Inc
ABMD
| $3.49M | 0.07% |
20,698
-9,190
| -31% | -$1.39M |
|
315
PG&E
PCG
$47.8B
| $3.49M | 0.07% |
51,219
-2,421
| -5% | -$166K |
|
316
Primoris Services
PRIM
$4.69B
| $3.48M | 0.07% |
118,102
+32,400
| +38% | +$863K |
|
|
NXGN
317
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $3.45M | 0.07% |
219,361
+24,250
| +12% | +$391K |
|
|
BDN
318
Brandywine Realty Trust
BDN
$551M
| $3.44M | 0.07% |
196,814
+2,400
| +1% | +$40.8K |
|
319
Commercial Metals
CMC
$7.63B
| $3.36M | 0.07% |
176,391
-4,600
| -3% | -$86.2K |
|
320
Crocs
CROX
$6.69B
| $3.36M | 0.07% |
346,119
+260,247
| +303% | +$2.23M |
|
321
WaFd
WAFD
$2.72B
| $3.31M | 0.06% |
98,519
-6,500
| -6% | -$211K |
|
322
Kulicke & Soffa
KLIC
$5.3B
| $3.31M | 0.06% |
153,211
-20,671
| -12% | -$415K |
|
323
Koppers
KOP
$966M
| $3.29M | 0.06% |
71,405
+2,780
| +4% | +$108K |
|
324
AeroVironment
AVAV
$7.57B
| $3.25M | 0.06% |
60,032
-23,930
| -29% | -$1.02M |
|
325
Scholastic
SCHL
$796M
| $3.25M | 0.06% |
87,351
-11,050
| -11% | -$443K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2017 Portfolio in Review
As of Q3 2017, Jacobs Levy Equity Management held 1,074 positions worth $5.14B, up 10% from $4.68B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jacobs Levy Equity Management deployed $273M of net new capital in Q3 2017, opening 159 new positions and adding to 412 existing holdings. Its largest new stake was Allergan plc: 114,141 shares worth $23.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Intuit, an estimated $26.1M trimmed.
- Jacobs Levy Equity Management's largest Q3 2017 buy was Allergan plc: 114,141 shares worth $23.4M.
- Jacobs Levy Equity Management added most to Philip Morris in Q3 2017, an estimated $28.6M increase.
- Jacobs Levy Equity Management's biggest Q3 2017 reduction was Intuit, cutting an estimated $26.1M.
- Jacobs Levy Equity Management fully exited BWX Technologies in Q3 2017, selling an estimated $13.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 11% of its $5.14B portfolio in Q3 2017.
- Jacobs Levy Equity Management opened 159 new positions and closed 136 in Q3 2017.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $5.14B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2017, filed 14 Nov 2017.